user

Targeting Estrogen Receptor (ER) Mutations for Treatment of Endocrine Therapy Resistance in Breast Cancer

被引：1
|
作者：
Alluri, P. G. [1 ]
Larios, J. [1 ]
Malik, R. [1 ]
Rae, J. [1 ]
Chinnaiyan, A. [2 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.139
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [41] Regulation of Notch localization by endocrine therapy in Estrogen Receptor positive breast cancer cells: Clinical implications for endocrine resistance
    Espinoza, I.
    Caskey, M.
    Baker, R. C.
    Miele, L.
    CANCER RESEARCH, 2012, 72
  • [42] Contribution of ERα/PR crosstalk to endocrine therapy resistance in breast cancer
    Huggins, Rosemary J.
    CANCER RESEARCH, 2020, 80 (16)
  • [43] New insight into estrogen receptor-α function and its implication for endocrine therapy resistance in breast cancer
    Schiff, R
    Osborne, CK
    BREAST CANCER RESEARCH, 2005, 7 (05) : 205 - 211
  • [44] Endocrinology and hormone therapy in breast cancer: New insight into estrogen receptor-α function and its implication for endocrine therapy resistance in breast cancer
    Rachel Schiff
    C Kent Osborne
    Breast Cancer Research, 7
  • [45] THE USE OF ADJUVANT ENDOCRINE THERAPY IN OLDER WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER (BC)
    Aapro, M.
    Crivellari, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 208 - 209
  • [46] Neoadjuvant endocrine therapy for estrogen receptor (ER) positive breast cancer: Comprehensive systematic review and meta-analysis
    Spring, L.
    Gupta, A.
    Reynolds, K. L.
    Gadd, M. A.
    Isakoff, S. J.
    Ellisen, L. W.
    Moy, B.
    Bardia, A.
    CANCER RESEARCH, 2016, 76
  • [47] Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
    Shi, Liang
    Dong, Bin
    Li, Zhongwu
    Lu, Yunwei
    Tao Ouyang
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Wang, Zhaoyi
    Xie, Yuntao
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3423 - 3429
  • [48] Expression of ER-a36, a novel variant of estrogen receptor a, and resistance to tamoxifen treatment in breast cancer
    Shi, L.
    Dong, B.
    Li, Z.
    Lu, Y.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Wang, Z.
    Xie, Y.
    CANCER RESEARCH, 2009, 69 (02) : 216S - 216S
  • [49] Acquired FGF and FGFR alterations confer resistance to estrogen receptor (ER) targeted therapy in metastatic ER plus breast cancer
    Mao, Pingping
    Cohen, Ofir
    Kowalski, Kailey
    Kusiel, Justin
    Buendia, Jorge
    Exman, Pedro
    Wander, Seth A.
    Waks, Adrienne G.
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    CANCER RESEARCH, 2019, 79 (13)
  • [50] Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer
    Mao, Pingping
    Cohen, Ofir
    Kowalski, Kailey J.
    Kusiel, Justin G.
    Buendia-Buendia, Jorge E.
    Cuoco, Michael S.
    Exman, Pedro
    Wander, Seth A.
    Waks, Adrienne G.
    Nayar, Utthara
    Chung, Jon
    Freeman, Samuel
    Rozenblatt-Rosen, Orit
    Miller, Vincent A.
    Piccioni, Federica
    Root, David E.
    Regev, Aviv
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5974 - 5989
12345